Stocky turns companies like Abivax SA into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Avoid. AAVXF scores poorly across fundamental dimensions: a Value Compounder Score of 14/100 signals weak cash generation and returns on capital, while a Leadership Alignment Score of 45/100 suggests misalignment between management incentives and shareholder interests. The Vulnerability Index sits at neutral (50/100) with no specific moat or structural risk identified, leaving the company exposed to competitive and cyclical pressures without clear defensibility.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Abivax SA:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 31/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Abivax SA (AAVXF) at 31/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. AAVXF scores poorly across fundamental dimensions: a Value Compounder Score of 14/100 signals weak cash generation and returns on capital, while a Leadership Alignment Score of 45/100 suggests misalignment between management incentiv
AAVXF's current Stocky Verdict is 31/100, placing it in the "Avoid" band. This composite combines a 14/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Abivax SA yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Abivax SA scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Abivax SA's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Abivax SA.
Sign up free and unlock the full analysis on AAVXF — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for AAVXF in the app.
